Case number 1:18-cv-00189
Takeda Pharmaceuticals U.S.A., Inc. v. Alkem Laboratories Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 9, 2018 | 17 | Main Document (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s): 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; 7,619,004; 7,601,758, 7,820,681, 7,915,269, 7,964,647, 7,981,938, 8,093,296, 8,097,655, 8,415,395, 8,415,396, 8,440,721, 8,440,722. (Attachments: # (1) Order)(nms) |
| Jul 9, 2018 | 17 | Order (2) |
| Jul 9, 2018 | 17 | Patent/Trademark Report to Commissioner (2) |
| Jul 6, 2018 | 16 | Order (2) Docket Text: SO ORDERED Granting [15] Stipulation of Dismissal (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 7/6/2018. (nms) |
| Jul 6, 2018 | 15 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal Without Prejudice and Proposed Order, by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) Modified on 7/6/2018 (nms). |
| May 24, 2018 | 14 | Order (2) Docket Text: SO ORDERED Granting [13] Stipulation and Order to Stay Action Pending Regulatory Review of Settlement. Signed by Judge Richard G. Andrews on 5/23/2018. (nms) |
| May 22, 2018 | 13 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Stay Action Pending Regulatory Review of Settlement by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) |
| Apr 23, 2018 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney A. Neal Seth, Rachel Hunnicutt and Alexander Owczarczak of Wiley Rein LLP, filed by Alkem Laboratories Limited, Ascend Laboratories, LLC. Signed by Judge Richard G. Andrews on 4/23/2018. (nms) |
| Apr 20, 2018 | 12 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney A. Neal Seth, Rachel Hunnicutt and Alexander Owczarczak of Wiley Rein LLP - filed by Alkem Laboratories Limited, Ascend Laboratories, LLC. (Metzler, Sara) |
| Apr 16, 2018 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Heather E. Takahashi,Jeffrey I. Weinberger,Elizabeth A. Laughton,Ted G. Dane for Takeda Pharmaceuticals U.S.A., Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm) |
| Apr 16, 2018 | N/A | Add Attorneys Pro Hac Vice (0) |
| Apr 12, 2018 | 11 | Motion for Leave to Appear Pro Hac Vice (7) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey I. Weinberger, Ted G. Dane, Heather E. Takahashi, Elizabeth A. Laughton, and Hannah Dubina - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attaway, Daniel) |
| Apr 12, 2018 | N/A | SO ORDERED (0) |
| Apr 2, 2018 | 10 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Alkem Laboratories Ltd. for Ascend Laboratories, LLC filed by Ascend Laboratories, LLC. (Farnan, Kelly) |
| Apr 2, 2018 | 9 | Disclosure Statement (1) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying filed by Alkem Laboratories Limited. (Farnan, Kelly) |
| Apr 2, 2018 | 8 | Answer to Complaint (30) Docket Text: ANSWER to [1] Complaint,, by Alkem Laboratories Limited, Ascend Laboratories, LLC.(Farnan, Kelly) |
| Feb 7, 2018 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (nms) |
| Feb 6, 2018 | 7 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc.: For Ascend Laboratories, LLC waiver sent on 2/1/2018, answer due 4/2/2018. (Attaway, Daniel) |
| Feb 6, 2018 | 6 | Waiver of Service Executed (1) Docket Text: WAIVER OF SERVICE returned executed by Takeda Pharmaceuticals U.S.A., Inc.: For Alkem Laboratories Limited waiver sent on 2/1/2018, answer due 4/2/2018. (Attaway, Daniel) |
| Feb 1, 2018 | 1 | Complaint (40) |
| Feb 1, 2018 | 1 | Exhibit S (26) |
| Feb 1, 2018 | 1 | Exhibit T (7) |
| Feb 1, 2018 | 1 | Exhibit U (4) |
| Feb 1, 2018 | 1 | Civil Cover Sheet (2) |
| Feb 1, 2018 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (nmg) |
| Feb 1, 2018 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/24/2017. Date of Expiration of Patent: See Attached.Thirty Month Stay Deadline: 6/24/2020. (nmg) |
| Feb 1, 2018 | 4 | Patent/Trademark Report to Commissioner (2) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,906,519; 7,935,731; 8,093,298; 7,964,648; 8,093,297; 7,619,004; 7,601,758, 7,820,681, 7,915,269, 7,964,647, 7,981,938, 8,093,296, 8,097,655, 8,415,395, 8,415,396, 8,440,721, 8,440,722. (nmg) |
| Feb 1, 2018 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Takeda Pharmaceutical Company Limited, Corporate Parent Takeda Pharmaceuticals International AG for Takeda Pharmaceuticals U.S.A., Inc. filed by Takeda Pharmaceuticals U.S.A., Inc. (nmg) |
| Feb 1, 2018 | 1 | Exhibit R (27) |
| Feb 1, 2018 | 1 | Exhibit Q (31) |
| Feb 1, 2018 | 1 | Exhibit P (31) |
| Feb 1, 2018 | 1 | Exhibit O (19) |
| Feb 1, 2018 | 1 | Exhibit N (19) |
| Feb 1, 2018 | 1 | Exhibit M (35) |
| Feb 1, 2018 | 1 | Exhibit L (36) |
| Feb 1, 2018 | 1 | Exhibit K (28) |
| Feb 1, 2018 | 1 | Exhibit J (26) |
| Feb 1, 2018 | 1 | Exhibit I (16) |
| Feb 1, 2018 | 1 | Exhibit H (16) |
| Feb 1, 2018 | 1 | Exhibit G (27) |
| Feb 1, 2018 | 1 | Exhibit F (29) |
| Feb 1, 2018 | 1 | Exhibit E (19) |
| Feb 1, 2018 | 1 | Exhibit D (16) |
| Feb 1, 2018 | 1 | Exhibit C (23) |
| Feb 1, 2018 | 1 | Exhibit B (16) |
| Feb 1, 2018 | 1 | Exhibit A (25) |
| Feb 1, 2018 | 1 | Main Document (40) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against Alkem Laboratories Limited, Ascend Laboratories, LLC - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2313683.) - filed by Takeda Pharmaceuticals U.S.A., Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Exhibit E, # (6) Exhibit F, # (7) Exhibit G, # (8) Exhibit H, # (9) Exhibit I, # (10) Exhibit J, # (11) Exhibit K, # (12) Exhibit L, # (13) Exhibit M, # (14) Exhibit N, # (15) Exhibit O, # (16) Exhibit P, # (17) Exhibit Q, # (18) Exhibit R, # (19) Exhibit S, # (20) Exhibit T, # (21) Exhibit U, # (22) Civil Cover Sheet)(nmg) |
| Feb 1, 2018 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Alkem Laboratories Limited on 2/1/2018; Ascend Laboratories, LLC on 2/1/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (nmg) |
| Feb 1, 2018 | 1 | Complaint* (1) |
